ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q2Scopus Q2SCImago #8,437Diamond OAGold OA

Australian Prescriber

Abbreviation (ISO):AUST PRESCR
•
Identifier (ISSN):0312-8008(Print)/1839-3942(Online)
•
Publisher:National Prescribing Service
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
4.3↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Australian Prescriber

WoS Q2
024602018020192.720233.420244.220254.32026
Annual Impact Factor Metric
Current (2026):4.3
Scopus SJR & RankScopus Q2
0.687
#8,437

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
50

50 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
24articles/year
100% Gold OA•100% Original Research

Aims & Scope

Australian Prescriber is Australia's free, national, independent journal of drugs and therapeutics. It is published every two months online. Our purpose is to help health professionals make informed choices when prescribing, including whether to prescribe a drug or not. To do this we provide independent, reliable and accessible information. As well as publishing short didactic reviews, we facilitate debate about complex, controversial or uncertain therapeutic areas. We are part of NPS MedicineWise, an independent, non-profit organisation providing medicines information and resources for health professionals, and stakeholders involved in the quality use of medicines. NPS MedicineWise is funded by the Australian Government Department of Health.

Topics Covered (Recognized by AI)
MedicineBiologyPharmacologyInternal MedicinePsychologyPsychiatryGeneticsChemistryIntensive Care Medicine

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q2
Rank95/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q2
Rank92/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.3
Articles / Year26
Total Citations2
2025
IF4.2
Articles / Year57
Total Citations109
2024
IF3.4
Articles / Year56
Total Citations205
2023
IF2.7
Articles / Year32
Total Citations215
2022
IF—
Articles / Year78
Total Citations475

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,437Scopus Q2Diamond OASCImago Profile
Scopus Coverage:1995-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.687

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.49

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations235
3-Year Documents158
Citable Documents74

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate62.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Australian Prescriber (abbr: AUST PRESCR, ISSN: 0312-8008) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by National Prescribing Service in Australia since 1975. The periodical holds a Journal Impact Factor (JIF) of 4.30, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.687 (Q2), an H-index of 50.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 24 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
National Prescribing Service
Publication Language
English
Frequency
Bimonthly
Founding Year
1975
Indexing & Databases
ESCIScopusDOAJPubMed
Editorial Address
NATIONAL PRESCRIBING SERVICE LTD, SUITE 3, 2 PHIPPS CLOSE, DEAKIN, AUSTRALIA, ACT 2600

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5d19afb1-2d46-4dbf-bda2-ac0475af4678
Database Updated: 2026-09-28